---
input_text: "Heart Rate Variability in Huntington Disease: A Long-Term Longitudinal
  Study. INTRODUCTION: The aim of the study was to follow tonic and phasic autonomic
  nervous activity in Huntington disease (HD) mutation carriers and patients. METHODS:
  Evaluation of motor functions and total functional capacity was performed in 30
  HD mutation carriers or patients at the beginning and in 22 subjects after 8-10
  years. Continuous arterial blood pressure, heart rate (HR), and ECG at rest were
  measured, and HR variability analysis was performed in four different ways. A group
  of matched controls was also evaluated. RESULTS: Eighteen subjects were assorted
  in 3 groups: 6 HD mutation carriers without motor symptoms (PHD) who remained so
  (PHD-PHD); 6 early symptomatic patients (EHD) who remained so (EHD-EHD); and 6 early
  symptomatic patients who deteriorated to a late symptomatic (LHD) (EHD-LHD). At
  the beginning, sympathetic tonic activity in PHD was elevated, according to mean
  arterial pressure (99 +- 10.6 mm Hg) higher than in controls (85 +- 8.7 mm Hg) and
  EHD (82 +- 9.9 mm Hg) (Dunnett's test, p < 0.05) and higher HR (78 +- 16 beats/min)
  than after 8-10 years (64 +- 11.3 beats/min) (paired t test, p < 0.05). There was
  also a decreased phasic sympathetic activity in EHD patients compared controls at
  the beginning (219 +- 106 vs. 664 +- 466 s2/Hz) and after 8-10 years (182 +- 136
  vs. 1,012 +- 1,369 s2/Hz) (Dunnett's test, p < 0.05). In patients who deteriorated
  from EHD to LHD, there was a drop in phasic parasympathetic activity from 887 +-
  433 to 230 +- 235 s2/Hz (paired t test, p < 0.05). CONCLUSIONS: Our long-term observational
  study provides important information on the timeline of ANS activity in HD progress.
  There was a temporary increase in cardiac and vascular sympathetic activity in PHD
  subjects. The normalization of HR in PHD subjects might indicate the approach of
  an outbreak of clinical disease phase."
raw_completion_output: |-
  primary_disease: Huntington Disease

  medical_actions: Evaluation of motor functions and total functional capacity; Measurement of continuous arterial blood pressure; Heart rate measurement; ECG at rest; Heart rate variability analysis

  symptoms: Elevated sympathetic tonic activity; Higher mean arterial pressure; Increased heart rate; Decreased phasic sympathetic activity; Drop in phasic parasympathetic activity

  chemicals: 

  action_annotation_relationships: Evaluation of motor functions and total functional capacity TREATS Elevated sympathetic tonic activity IN Huntington Disease; Measurement of continuous arterial blood pressure TREATS Higher mean arterial pressure IN Huntington Disease; Heart rate measurement TREATS Increased heart rate IN Huntington Disease; ECG at rest PREVENTS Decreased phasic sympathetic activity IN Huntington Disease; Heart rate variability analysis TREATS Drop in phasic parasympathetic activity IN Huntington Disease
prompt: |+
  From the text below, extract the following entities in the following format:

  subject_extension: <A chemical or drug mentioned in the relationship between the medical action and the symptom, for example, "analgesic agent therapy" has the aspect "analgesic">
  object_extension: <An optional term describing some specific aspect of the object, e.g. "analgesic agent therapy" has the aspect "analgesic">
  subject: <The medical action. For example: blood transfusion, radiation therapy, cardiac catheterization, pulse oximetry, otoscopy>
  predicate: <The relationship type between the medical action and the symptom, usually TREATS or PREVENTS.>
  object: <A sign or symptom associated with the disease and targeted by the medical action. For example, Low serum calcitriol, hypoplasia of the thymus, chronic cough, aortic stiffness, low pulse pressure>
  qualifier: <The primary disease the relationship is about, or specifically the disease the symptom is related to. For example, Beck-Fahrner syndrome, hereditary retinoblastoma, progeria, diabetes mellitus, infectious otitis media>
  subject_qualifier: <An optional qualifier or modifier for the subject of the statement, e.g. "high dose" or "intravenously administered">
  object_qualifier: <An optional qualifier or modifier for the object of the statement, e.g. "severe" or "with additional complications">


  Text:
  Heart rate variability analysis TREATS Drop in phasic parasympathetic activity IN Huntington Disease

  ===

extracted_object:
  primary_disease: MONDO:0007739
  medical_actions:
    - Evaluation of motor functions and total functional capacity
    - Measurement of continuous arterial blood pressure
    - MAXO:0000490
    - ECG at rest
    - Heart rate variability analysis
  symptoms:
    - Elevated sympathetic tonic activity
    - Higher mean arterial pressure
    - HP:0001649
    - Decreased phasic sympathetic activity
    - Drop in phasic parasympathetic activity
  action_annotation_relationships:
    - subject: Evaluation of motor functions and total functional capacity
      predicate: TREATS
      object: Elevated sympathetic tonic activity
      qualifier: MONDO:0007739
    - subject: Measurement of continuous arterial blood pressure
      predicate: TREATS
      object: Higher mean arterial pressure
      qualifier: MONDO:0007739
    - subject: MAXO:0000490
      predicate: TREATS
      object: HP:0001649
      qualifier: MONDO:0007739
    - subject: ECG at rest
      predicate: PREVENTS
      object: Decreased phasic sympathetic activity
      qualifier: MONDO:0007739
    - subject: Heart rate variability analysis
      predicate: TREATS
      object: Drop in phasic parasympathetic activity
      qualifier: MONDO:0007739
named_entities:
  - id: MONDO:0007739
    label: Huntington Disease
  - id: CHEBI:16908
    label: NADH
  - id: HP:0002180
    label: neurodegeneration
  - id: MAXO:0001001
    label: gene therapies
  - id: MAXO:0000127
    label: genetic testing
  - id: MONDO:0020696
    label: Vitamin B12 Deficiency
  - id: MAXO:0000760
    label: Vitamin B12 supplementation
  - id: MAXO:0000427
    label: MRI of the brain
  - id: CHEBI:176843
    label: Vitamin B12
  - id: MONDO:0020380
    label: Spinocerebellar Ataxia (SCA)
  - id: HP:0001272
    label: Cerebellar atrophy
  - id: MONDO:0004975
    label: Alzheimer's disease
  - id: MONDO:0017276
    label: frontotemporal dementia
  - id: MONDO:0004976
    label: amyotrophic lateral sclerosis
  - id: MONDO:0007661
    label: Tourette Syndrome
  - id: HP:0002072
    label: Chorea
  - id: MONDO:0005071
    label: Neurological Disorders
  - id: MAXO:0000647
    label: Chemotherapy
  - id: HP:0100543
    label: Cognitive impairment
  - id: HP:0012174
    label: glioblastoma
  - id: MONDO:0005109
    label: HIV
  - id: MONDO:0005559
    label: Neurodegenerative diseases
  - id: CHEBI:16243
    label: quercetin
  - id: CHEBI:3962
    label: curcumin
  - id: CHEBI:27881
    label: resveratrol
  - id: CHEBI:75095
    label: chrysin
  - id: CHEBI:28821
    label: piperine
  - id: CHEBI:17620
    label: ferulic acid
  - id: CHEBI:78330
    label: huperzine A
  - id: CHEBI:16118
    label: berberine
  - id: CHEBI:2979
    label: baicalein
  - id: CHEBI:28230
    label: hesperetin
  - id: CHEBI:26536
    label: retinoic acid
  - id: HP:0002015
    label: Dysphagia
  - id: CHEBI:50202
    label: Naringenin
  - id: CHEBI:16348
    label: 3-nitropropionic acid
  - id: CHEBI:28790
    label: Serotonin
  - id: HP:0000709
    label: psychosis
  - id: HP:0011951
    label: aspiration pneumonia
  - id: HP:0000716
    label: depression
  - id: MAXO:0000065
    label: aerobic exercises
  - id: MAXO:0000610
    label: enzyme-linked immunosorbent assays
  - id: CHEBI:53444
    label: potassium dichromate
  - id: CHEBI:141442
    label: Manganese (Mn)
  - id: HP:0100021
    label: Cerebral palsy
  - id: HP:0001915
    label: Aplastic anemia
  - id: MAXO:0000079
    label: genetic counseling
  - id: HP:0000708
    label: behavioral problems
  - id: HP:0004421
    label: Elevated systolic blood pressure
  - id: MONDO:0005180
    label: Parkinson disease
  - id: MONDO:0005098
    label: stroke
  - id: MONDO:0005301
    label: multiple sclerosis
  - id: HP:0000739
    label: anxiety
  - id: CHEBI:7872
    label: oxytocin
  - id: CHEBI:9937
    label: vasopressin
  - id: HP:0033429
    label: neuroinflammation
  - id: MAXO:0000016
    label: Cell Therapy
  - id: CHEBI:6437
    label: levetiracetam
  - id: MAXO:0000900
    label: Electrocardiograms (ECGs) collection
  - id: HP:0040141
    label: Tardive dyskinesia
  - id: MONDO:0010096
    label: tardive dyskinesia
  - id: HP:0005268
    label: Spontaneous abortion
  - id: CHEBI:16675
    label: quinolinic acid
  - id: MONDO:0001627
    label: Dementias
  - id: HP:0001300
    label: parkinsonism
  - id: CHEBI:76720
    label: antisense oligonucleotide
  - id: CHEBI:192545
    label: LY379268
  - id: HP:0005305
    label: cerebral venous thrombosis
  - id: HP:0001891
    label: iron-deficiency anemia
  - id: HP:0001875
    label: neutropenia
  - id: HP:0000657
    label: Ocular Motor Apraxia
  - id: HP:0025464
    label: Oxidative stress
  - id: HP:0003287
    label: Mitochondrial dysfunction
  - id: HP:0002511
    label: Alzheimer's disease
  - id: HP:0001297
    label: Stroke
  - id: MAXO:0009004
    label: Exome sequencing
  - id: HP:0001251
    label: Ataxia
  - id: HP:0000726
    label: Dementia
  - id: HP:0001332
    label: Dystonia
  - id: HP:0002313
    label: Spastic paraparesis
  - id: HP:0000789
    label: infertility
  - id: MAXO:0000137
    label: PET scan
  - id: HP:0000750
    label: Speech Difficulties
  - id: HP:0002446
    label: Astrogliosis
  - id: CHEBI:76931
    label: N-acetylaspartylglutamate
  - id: MONDO:0005395
    label: Movement disorders
  - id: HP:0100033
    label: Tic disorders
  - id: CHEBI:50114
    label: Oestrogens
  - id: CHEBI:50113
    label: Androgens
  - id: MAXO:0000068
    label: transplantation
  - id: MAXO:0000943
    label: Deep brain stimulation (DBS)
  - id: CHEBI:15765
    label: Levodopa
  - id: MONDO:0024331
    label: Colorectal cancer (CRC)
  - id: MONDO:0005575
    label: Colorectal cancer
  - id: HP:0002093
    label: respiratory insufficiency
  - id: MONDO:0011426
    label: aceruloplasminemia
  - id: MAXO:0000490
    label: Heart rate measurement
  - id: HP:0001649
    label: Increased heart rate
